Engineered immunogen binding to alum adjuvant enhances humoral immunity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-18
DOI
10.1038/s41591-020-0753-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
- (2018) Robert K. Abbott et al. IMMUNITY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
- (2018) Colin Havenar-Daughton et al. Science Translational Medicine
- Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization
- (2018) Matteo Bianchi et al. IMMUNITY
- Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
- (2018) Harm HogenEsch et al. npj Vaccines
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
- (2017) Matthias Pauthner et al. IMMUNITY
- Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
- (2017) Colin Havenar-Daughton et al. IMMUNOLOGICAL REVIEWS
- Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
- (2017) Daniel W. Kulp et al. Nature Communications
- Impact of adjuvants on CD4 + T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial
- (2016) Geert Leroux-Roels et al. CLINICAL IMMUNOLOGY
- HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
- (2016) Jon M. Steichen et al. IMMUNITY
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- In vitro reconstitution of B cell receptor–antigen interactions to evaluate potential vaccine candidates
- (2016) Grant C Weaver et al. Nature Protocols
- Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
- (2016) D. Sok et al. SCIENCE
- HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
- (2016) J. G. Jardine et al. SCIENCE
- Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity
- (2015) Joyce K. Hu et al. JOURNAL OF VIROLOGY
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
- (2015) J. G. Jardine et al. SCIENCE
- Analysis of immunoglobulin transcripts and hypermutation following SHIVAD8 infection and protein-plus-adjuvant immunization
- (2015) Joseph R. Francica et al. Nature Communications
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- Full-length RNA-seq from single cells using Smart-seq2
- (2014) Simone Picelli et al. Nature Protocols
- Single-cell based high-throughput sequencing of full-length immunoglobulin heavy and light chain genes
- (2013) Christian E. Busse et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
- (2013) Marcella Sarzotti-Kelsoe et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway
- (2013) Esin Güven et al. PLoS One
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker
- (2013) Fangjia Lu et al. VACCINE
- Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
- (2012) Tirth R. Ghimire et al. IMMUNOLOGY LETTERS
- CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation
- (2011) Lina E. Tze et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alum adjuvant: some of the tricks of the oldest adjuvant
- (2011) M. Kool et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Alhydrogel® adjuvant, ultrasonic dispersion and protein binding: A TEM and analytical study
- (2011) J. Robin Harris et al. MICRON
- A 2020 vision for vaccines against HIV, tuberculosis and malaria
- (2011) Rino Rappuoli et al. NATURE
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
- (2011) Tracy L Flach et al. NATURE MEDICINE
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- (2010) S. Khurana et al. Science Translational Medicine
- Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response
- (2010) Stephanie M. Noe et al. VACCINE
- TopHat: discovering splice junctions with RNA-Seq
- (2009) Cole Trapnell et al. BIOINFORMATICS
- Identification and Suppression of β-Elimination Byproducts Arising from the Use of Fmoc-Ser(PO3Bzl,H)-OH in Peptide Synthesis
- (2009) Troy J. Attard et al. International Journal of Peptide Research and Therapeutics
- Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine
- (2009) Patricia M. Egan et al. VACCINE
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search